Sector: Healthcare | Industry: Biotechnology & Medical Research |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 221 Crescent St. Building 17, Suite 102b WALTHAM MA 02453 |
Tel: | N/A |
Website: | https://apogeetherapeutics.com |
IR: | See website |
Key People | ||
Mark C. McKenna Chairman of the Board | Michael Henderson Chief Executive Officer, Director | Jane Pritchett Henderson Chief Financial Officer | Carl Dambkowski Chief Medical Officer |
Business Overview |
N/A |
Financial Overview |
For the fiscal year ended 31 December 2023, Apogee Therapeutics Inc revenues was not reported. Net loss increased from $39.8M to $84M. Higher net loss reflects biotechnology segment loss increase from $30.7M to $93M. Basic Earnings per Share excluding Extraordinary Items decreased from -$0.84 to -$1.74. |